Syntheia Labs leases space at TSRLabs’ Ann Arbor headquarters

Syntheia Labs will establish operations inside TSRLabs’ Ann Arbor life sciences headquarters, bringing another biotech company into Michigan’s research ecosystem. The move is aimed at deepening collaboration between preclinical scientists and emerging drug development teams.

Why it matters: - Syntheia Labs’ move into TSRLabs’ Ann Arbor headquarters adds another growing life sciences company to Michigan’s biotech cluster. - The co-location is designed to increase collaboration between preclinical experts and emerging biotech teams. - TSRLabs says the arrangement supports scientific exchange that can help drug developers make better decisions earlier.

What happened: - TSRLabs announced that Syntheia Labs signed a lease to establish operations inside TSRLabs’ Ann Arbor headquarters. - The companies said the partnership creates new opportunities for scientific collaboration in Michigan. - Syntheia Labs will work alongside TSRLabs in the same facility as it continues scaling its preclinical CRO services.

The details: - Syntheia Labs builds high-resolution data packages and customized preclinical CRO services aimed at predicting structural heart risk in active drug pipelines. - The company uses proprietary in-house 3D human heart tissue paired with advanced genomics. - Syntheia Labs says its datasets help partners reduce preventable late-stage clinical failures. - Merlinda-Loriane Sewavi, MS, leads Syntheia Labs as CEO. - Syntheia Labs serves AI computational biology platforms, preclinical CROs and global pharmaceutical companies. - TSRLabs is a preclinical CRO focused on testing services and early-stage development strategy. - TSRLabs’ work includes formulation development, bioanalysis, exploratory toxicology and pharmacokinetic strategies to guide human dosing schedules. - TSRLabs supports pharmaceutical, biotechnology, academic and government partners from Michigan. - Syntheia Labs has received investment from Red Cedar Ventures and 84|90. - Syntheia Labs graduated from the Henry Ford Innovations x MSU Research Foundation accelerator. - TSRLabs included a partnership link at More information. - Syntheia Labs lists its website at the company’s website and its LinkedIn page at LinkedIn profile.

Between the lines: - The move reflects a broader effort to keep more early-stage biotech activity in the Ann Arbor region. - TSRLabs is positioning its headquarters as a place where established pharmaceutical scientists and newer biotechnology companies can share space and expertise. - Syntheia Labs is using the location to place its data and lab teams closer to preclinical know-how as it scales. - The companies are also framing the relationship as part of Michigan’s push to strengthen its role in biotech innovation.

What's next: - Syntheia Labs will begin operating from TSRLabs’ headquarters as it expands its CRO offerings. - TSRLabs expects the shared environment to create more collaboration opportunities for teams working on therapeutic development. - Both companies say the Ann Arbor placement should help attract more promising life sciences firms to the region.

The bottom line: - The lease gives Syntheia Labs a home inside an established preclinical research hub and gives TSRLabs another tenant aligned with its collaboration-first strategy.